摘要
随着全球糖尿病患病率的不断攀升,糖尿病患者群呈现多样化的特点。除了成人T1DM和T2DM外,儿童和青少年糖尿病、妊娠期糖尿病(GDM)及老年糖尿病患者人数也不断增多。针对不同人群的特点和对血糖控制的特殊要求,多项国际指南均强调"以患者为中心"的治疗理念,设定个体化的血糖控制目标和治疗方案。速效胰岛素类似物门冬胰岛素,拥有广泛的适用人群,用于胰岛素强化治疗方案可有效控制餐后血糖,降低低血糖发生风险,且门冬胰岛素餐前或餐后即刻注射均可安全有效控糖,注射方式灵活方便,能更好地满足不同糖尿病患者的个体化血糖管理的需求,提高患者的生活质量和治疗依从性,从而实现更好的血糖控制。
With the prevalence of diabetes mellitus,the patient demography is changing greatly.In addition to adult type 1 and type 2 diabetes,the number of patients with diabetes in children and adolescents,pregnant womenand elder are increasing rapidly.On account of the difference andspecial requirements for diabetes management of different patients,a number of international guidelines emphasize apatient-centeredapproach and set special goals and individual therapies for glycaemic control.Insulin aspart as a rapid acting insulin analogue can be used in a broad range of patient types.When used in insulin intensification therapy,insulin aspart demonstrates the efficacy and safety profile,offers flexible dosing,which prove to help reach the aged-special HbA1 c goals and improve the quality of life.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2014年第10期956-959,共4页
Chinese Journal of Diabetes
关键词
糖尿病
个体化管理
门冬胰岛素
Diabetes mellitus
Individual management
Insulin aspart
